Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 7/20 | 0.57 |
| ▸ | MC4R | P32245 | 13/20 | 0.56 |
| ▸ | MC3R | P41968 | 4/20 | 0.56 |
| ▸ | MC5R | P33032 | 3/20 | 0.56 |
| ▸ | MC1R | Q01726 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12536274 | 0.91 | MC4R (0.60) | PRCPMC4RMC3RMC5RMC1R | |
| SCHEMBL12536297 | 0.91 | MC4R (0.56) | PRCPMC4RMC3RMC5RMC1R | |
| SCHEMBL12536295 | 0.91 | PRCP (0.59) | PRCPMC4RMC3RMC5R | |
| SCHEMBL12536272 | 0.91 | PRCP (0.59) | PRCPMC4RMC3RMC5R | |
| SCHEMBL12536385 | 0.90 | PRCP (0.55) | PRCPMC4RMC3RMC5RMC1R | |
| SCHEMBL12536301 | 0.90 | PRCP (0.58) | PRCPMC4RMC3RMC5R | |
| SCHEMBL12536291 | 0.90 | PRCP (0.58) | PRCPMC4RMC3RMC5R | |
| SCHEMBL12536279 | 0.90 | PRCP (0.58) | PRCPMC4RMC3RMC5RMC1R | |
| SCHEMBL12536535 | 0.89 | PRCP (0.57) | PRCPMC4RMC3RMC5R | |
| SCHEMBL1947831 | 0.89 | MC4R (0.56) | PRCPMC4RMC3RMC5RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110136814-A1 | Diazepine and Diazocane Compounds As MC4 Agonists | ANDREWS MARK DAVID | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136814-A1 | Diazepine and Diazocane Compounds As MC4 Agonists | MC4R, CHRM4, GPR4 | PRCP 2814/4885MC4R 1/4885MC3R 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.